Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

APH vs CNXC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
APH
Amphenol Corporation

Hardware, Equipment & Parts

TechnologyNYSE • US
Market Cap$170.24B
5Y Perf.+323.5%
CNXC
Concentrix Corporation

Information Technology Services

TechnologyNASDAQ • US
Market Cap$1.67B
5Y Perf.-70.3%

APH vs CNXC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
APH logoAPH
CNXC logoCNXC
IndustryHardware, Equipment & PartsInformation Technology Services
Market Cap$170.24B$1.67B
Revenue (TTM)$25.90B$9.83B
Net Income (TTM)$4.48B$-1.28B
Gross Margin37.3%33.3%
Operating Margin26.0%6.2%
Forward P/E29.7x2.0x
Total Debt$15.50B$4.64B
Cash & Equiv.$11.13B$327M

APH vs CNXCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

APH
CNXC
StockNov 20May 26Return
Amphenol Corporation (APH)100423.5+323.5%
Concentrix Corporat… (CNXC)10029.6-70.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: APH vs CNXC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: APH leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Concentrix Corporation is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
APH
Amphenol Corporation
The Growth Play

APH carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 51.7%, EPS growth 74.0%, 3Y rev CAGR 22.3%
  • 9.2% 10Y total return vs CNXC's -63.2%
  • Lower volatility, beta 1.62, current ratio 2.98x
Best for: growth exposure and long-term compounding
CNXC
Concentrix Corporation
The Income Pick

CNXC is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 5 yrs, beta 1.38, yield 6.0%
  • Beta 1.38, yield 6.0%, current ratio 1.40x
  • Lower P/E (2.0x vs 29.7x)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthAPH logoAPH51.7% revenue growth vs CNXC's 2.2%
ValueCNXC logoCNXCLower P/E (2.0x vs 29.7x)
Quality / MarginsAPH logoAPH17.3% margin vs CNXC's -13.0%
Stability / SafetyCNXC logoCNXCBeta 1.38 vs APH's 1.62
DividendsAPH logoAPH0.5% yield, 15-year raise streak, vs CNXC's 6.0%
Momentum (1Y)APH logoAPH+74.8% vs CNXC's -50.0%
Efficiency (ROA)APH logoAPH13.6% ROA vs CNXC's -10.8%, ROIC 28.3% vs 5.6%

APH vs CNXC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

APHAmphenol Corporation
FY 2025
Communications Solutions
52.0%$12.2B
Harsh Environment Solutions
25.7%$6.0B
Interconnect Products And Assemblies
22.3%$5.2B
CNXCConcentrix Corporation
FY 2025
Reportable Segment
100.0%$9.8B

APH vs CNXC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAPHLAGGINGCNXC

Income & Cash Flow (Last 12 Months)

APH leads this category, winning 6 of 6 comparable metrics.

APH is the larger business by revenue, generating $25.9B annually — 2.6x CNXC's $9.8B. APH is the more profitable business, keeping 17.3% of every revenue dollar as net income compared to CNXC's -13.0%. On growth, APH holds the edge at +58.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAPH logoAPHAmphenol Corporat…CNXC logoCNXCConcentrix Corpor…
RevenueTrailing 12 months$25.9B$9.8B
EBITDAEarnings before interest/tax$7.9B$773M
Net IncomeAfter-tax profit$4.5B-$1.3B
Free Cash FlowCash after capex$4.6B$572M
Gross MarginGross profit ÷ Revenue+37.3%+33.3%
Operating MarginEBIT ÷ Revenue+26.0%+6.2%
Net MarginNet income ÷ Revenue+17.3%-13.0%
FCF MarginFCF ÷ Revenue+17.9%+5.8%
Rev. Growth (YoY)Latest quarter vs prior year+58.4%+4.3%
EPS Growth (YoY)Latest quarter vs prior year+24.1%-14.9%
APH leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

CNXC leads this category, winning 6 of 6 comparable metrics.

On an enterprise value basis, CNXC's 4.7x EV/EBITDA is more attractive than APH's 25.3x.

MetricAPH logoAPHAmphenol Corporat…CNXC logoCNXCConcentrix Corpor…
Market CapShares × price$170.2B$1.7B
Enterprise ValueMkt cap + debt − cash$174.6B$6.0B
Trailing P/EPrice ÷ TTM EPS41.46x-1.17x
Forward P/EPrice ÷ next-FY EPS est.29.69x2.03x
PEG RatioP/E ÷ EPS growth rate1.49x
EV / EBITDAEnterprise value multiple25.33x4.75x
Price / SalesMarket cap ÷ Revenue7.37x0.17x
Price / BookPrice ÷ Book value/share13.09x0.54x
Price / FCFMarket cap ÷ FCF38.88x2.91x
CNXC leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

APH leads this category, winning 7 of 9 comparable metrics.

APH delivers a 34.6% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $-33 for CNXC. APH carries lower financial leverage with a 1.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to CNXC's 1.69x. On the Piotroski fundamental quality scale (0–9), APH scores 6/9 vs CNXC's 5/9, reflecting solid financial health.

MetricAPH logoAPHAmphenol Corporat…CNXC logoCNXCConcentrix Corpor…
ROE (TTM)Return on equity+34.6%-33.2%
ROA (TTM)Return on assets+13.6%-10.8%
ROICReturn on invested capital+28.3%+5.6%
ROCEReturn on capital employed+25.5%+6.6%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage1.15x1.69x
Net DebtTotal debt minus cash$4.4B$4.3B
Cash & Equiv.Liquid assets$11.1B$327M
Total DebtShort + long-term debt$15.5B$4.6B
Interest CoverageEBIT ÷ Interest expense13.54x-3.07x
APH leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

APH leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in APH five years ago would be worth $42,142 today (with dividends reinvested), compared to $1,899 for CNXC. Over the past 12 months, APH leads with a +74.8% total return vs CNXC's -50.0%. The 3-year compound annual growth rate (CAGR) favors APH at 55.0% vs CNXC's -31.4% — a key indicator of consistent wealth creation.

MetricAPH logoAPHAmphenol Corporat…CNXC logoCNXCConcentrix Corpor…
YTD ReturnYear-to-date-0.7%-40.7%
1-Year ReturnPast 12 months+74.8%-50.0%
3-Year ReturnCumulative with dividends+272.5%-67.8%
5-Year ReturnCumulative with dividends+321.4%-81.0%
10-Year ReturnCumulative with dividends+917.7%-63.2%
CAGR (3Y)Annualised 3-year return+55.0%-31.4%
APH leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — APH and CNXC each lead in 1 of 2 comparable metrics.

CNXC is the less volatile stock with a 1.38 beta — it tends to amplify market swings less than APH's 1.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APH currently trades 82.9% from its 52-week high vs CNXC's 38.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAPH logoAPHAmphenol Corporat…CNXC logoCNXCConcentrix Corpor…
Beta (5Y)Sensitivity to S&P 5001.62x1.38x
52-Week HighHighest price in past year$167.04$62.14
52-Week LowLowest price in past year$79.10$22.85
% of 52W HighCurrent price vs 52-week peak+82.9%+38.2%
RSI (14)Momentum oscillator 0–10042.536.5
Avg Volume (50D)Average daily shares traded8.3M1.6M
Evenly matched — APH and CNXC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — APH and CNXC each lead in 1 of 2 comparable metrics.

Wall Street rates APH as "Buy" and CNXC as "Buy". Consensus price targets imply 119.2% upside for CNXC (target: $52) vs 30.2% for APH (target: $180). For income investors, CNXC offers the higher dividend yield at 6.00% vs APH's 0.45%.

MetricAPH logoAPHAmphenol Corporat…CNXC logoCNXCConcentrix Corpor…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$180.33$52.00
# AnalystsCovering analysts299
Dividend YieldAnnual dividend ÷ price+0.5%+6.0%
Dividend StreakConsecutive years of raises155
Dividend / ShareAnnual DPS$0.63$1.42
Buyback YieldShare repurchases ÷ mkt cap+0.4%+11.3%
Evenly matched — APH and CNXC each lead in 1 of 2 comparable metrics.
Key Takeaway

APH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNXC leads in 1 (Valuation Metrics). 2 tied.

Best OverallAmphenol Corporation (APH)Leads 3 of 6 categories
Loading custom metrics...

APH vs CNXC: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is APH or CNXC a better buy right now?

For growth investors, Amphenol Corporation (APH) is the stronger pick with 51.

7% revenue growth year-over-year, versus 2. 2% for Concentrix Corporation (CNXC). Amphenol Corporation (APH) offers the better valuation at 41. 5x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate Amphenol Corporation (APH) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — APH or CNXC?

On forward P/E, Concentrix Corporation is actually cheaper at 2.

0x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — APH or CNXC?

Over the past 5 years, Amphenol Corporation (APH) delivered a total return of +321.

4%, compared to -81. 0% for Concentrix Corporation (CNXC). Over 10 years, the gap is even starker: APH returned +917. 7% versus CNXC's -63. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — APH or CNXC?

By beta (market sensitivity over 5 years), Concentrix Corporation (CNXC) is the lower-risk stock at 1.

38β versus Amphenol Corporation's 1. 62β — meaning APH is approximately 17% more volatile than CNXC relative to the S&P 500. On balance sheet safety, Amphenol Corporation (APH) carries a lower debt/equity ratio of 115% versus 169% for Concentrix Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — APH or CNXC?

By revenue growth (latest reported year), Amphenol Corporation (APH) is pulling ahead at 51.

7% versus 2. 2% for Concentrix Corporation (CNXC). On earnings-per-share growth, the picture is similar: Amphenol Corporation grew EPS 74. 0% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, APH leads at 22. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — APH or CNXC?

Amphenol Corporation (APH) is the more profitable company, earning 18.

5% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 18. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: APH leads at 25. 9% versus 6. 2% for CNXC. At the gross margin level — before operating expenses — APH leads at 36. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is APH or CNXC more undervalued right now?

On forward earnings alone, Concentrix Corporation (CNXC) trades at 2.

0x forward P/E versus 29. 7x for Amphenol Corporation — 27. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNXC: 119. 2% to $52. 00.

08

Which pays a better dividend — APH or CNXC?

All stocks in this comparison pay dividends.

Concentrix Corporation (CNXC) offers the highest yield at 6. 0%, versus 0. 5% for Amphenol Corporation (APH).

09

Is APH or CNXC better for a retirement portfolio?

For long-horizon retirement investors, Concentrix Corporation (CNXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (6.

0% yield). Amphenol Corporation (APH) carries a higher beta of 1. 62 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CNXC: -63. 2%, APH: +917. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between APH and CNXC?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: APH is a mid-cap high-growth stock; CNXC is a small-cap income-oriented stock. CNXC pays a dividend while APH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

APH

High-Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 29%
  • Net Margin > 10%
Run This Screen
Stocks Like

CNXC

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Gross Margin > 19%
  • Dividend Yield > 2.3%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform APH and CNXC on the metrics below

Revenue Growth>
%
(APH: 58.4% · CNXC: 4.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.